Group-I	Control: 0.5 mL/kg/d, 1% carboxymethylcellulose (CMC), p.o. for 28 days +0.5 mL/kg normal saline, intraperitoneal (i.p.), over a period of 2 weeks (3rd and 4th week)
Group-II	DOX: 2.5 mg/kg in six equal i.p. injections over a period of 2 weeks (total cumulative dose of 15 mg/kg)
Group-III	CEL: 100 mg/kg/d, p.o. suspended in 1% CMC for 28 days
Group-IV	CEL + DOX: 100 mg/kg/d, p.o for 28 days +2.5 mg/kg, six equal i.p. injections over a period of 2 weeks (3rd and 4th weeks)
Group-V	FA: 10 mg/kg/d, p.o. suspended in 1% CMC for 28 days
Group-VI	CEL + FA: 100 mg/kg/d, p.o. for 28 days +10 mg/kg/d, p.o. for 28 days
Group-VII	CEL + FA + DOX: 100 mg/kg/d, p.o. for 28 days +10 mg/kg/d, p.o. for 28 days +2.5 mg/kg in six equal i.p injections over a period of 2 weeks (3rd and 4th weeks)